Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors
Julien Schmidt(Intensive Care Foundation), Alexandre Harari(University Hospital of Lausanne)
Cited by 66
Related Papers
Sensitive and frequent identification of high avidity neo-epitope specific CD8 + T cells in immunotherapy-naive ovarian cancer
|Nature Communications|2018|166
Improved predictions of antigen presentation and TCR recognition with MixMHCpred2.2 and PRIME2.0 reveal potent SARS-CoV-2 CD8+ T-cell epitopes
|Cell Systems|2023|114
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs
|Cell Reports Methods|2023|48